Medications

Is it time to nationalize the drug industry?

Critics of the pharmaceutical industry say it is misaligned with public interest. So is it time to nationalise the sector? Experts debate the issue in The BMJ today.

Diseases, Conditions, Syndromes

Risk, burden of diabetes up after acute SARS-CoV-2 infection

The risk and 12-month burden of incident diabetes is increased for individuals in the postacute phase of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, according to a study published online March ...

page 8 from 40